Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ablynx
Ablynx
(ABLX)
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Cablivi
Caplacizumab
2019-02-06
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Caplacizumab
healthy volunteers/patients
,
stable angina
,
unstable angina
Benzocaine
systemic lupus erythematosus
Histidine
healthy volunteers/patients
Sodium lactate
healthy volunteers/patients
OZORALIZUMAB
healthy volunteers/patients
,
rheumatoid arthritis
VOBARILIZUMAB
rheumatoid arthritis
,
systemic lupus erythematosus
Microcrystalline cellulose
healthy volunteers/patients
ALX-0171
healthy volunteers/patients
,
respiratory tract infections
,
respiratory syncytial virus infections
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use